Test group:Drug interventions
Sponsors
Taizhou People's Hospital, Huai'an First People's Hospital
Conditions
Esophageal cancerLung cancer
Phase 4
A Single-Arm, Open Phase II Clinical Trial of Iparomlimab and Tuvonralimab in Combination with Apatinib Mesylate and Capecitabine for Advanced Second-Line and Higher Esophageal Cancer
Active, not recruitingChiCTR2500100119
Start: 2025-04-02Updated: 2025-04-07
A prospective, multicenter, phase II clinical study of the Iparomlimab Tuvonralimab combination antibody in combination with chemotherapy for the translational treatment of nonsectable non-small cell lung cancer
Active, not recruitingChiCTR2500106888
Start: 2025-08-01Updated: 2025-08-18